Cabaletta Bio, Inc.
CABA
$3.04
$0.124.11%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -175.43M | -167.86M | -158.52M | -144.29M | -126.76M |
| Total Depreciation and Amortization | 1.50M | 1.65M | 1.77M | 1.85M | 1.80M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 37.79M | 35.51M | 33.79M | 30.98M | 27.23M |
| Change in Net Operating Assets | -6.70M | -379.00K | 4.11M | 6.79M | 2.69M |
| Cash from Operations | -142.84M | -131.08M | -118.86M | -104.67M | -95.04M |
| Capital Expenditure | -444.00K | -1.23M | -1.40M | -1.58M | -2.18M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1.92M | -49.04M | -86.54M | -24.04M | 49.50M |
| Cash from Investing | 1.48M | -50.27M | -87.94M | -25.61M | 47.32M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -9.98M | -6.26M | -5.25M | -4.45M | -1.45M |
| Issuance of Common Stock | 136.16M | 106.62M | 101.64M | 101.72M | 5.72M |
| Repurchase of Common Stock | -11.00K | -11.00K | -11.00K | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 126.17M | 100.35M | 96.39M | 97.26M | 4.27M |
| Foreign Exchange rate Adjustments | -1.00K | 19.00K | 7.00K | 18.00K | -13.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -15.20M | -80.98M | -110.40M | -33.00M | -43.46M |